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Abstract
Background: Following universal access to antiretroviral therapy in Thailand, evidence from National AIDS Spending 
Assessment indicates a decreasing proportion of expenditure on prevention interventions. To prompt policymakers to 
revitalize HIV prevention, this study identifies a comprehensive list of HIV/AIDs preventive interventions that are likely 
to be effective and cost-effective in Thailand.
Methods: A systematic review of the national and international literature on HIV prevention strategies from 1997 to 
2008 was undertaken. The outcomes used to consider the effectiveness of HIV prevention interventions were changes 
in HIV risk behaviour and HIV incidence. Economic evaluations that presented their results in terms of cost per HIV 
infection averted or cost per quality-adjusted life year (QALY) gained were also included. All studies were assessed 
against quality criteria.
Results: The findings demonstrated that school based-sex education plus life-skill programs, voluntary and routine HIV 
counselling and testing, male condoms, street outreach programs, needle and syringe programs, programs for the 
prevention of mother-to-child HIV transmission, male circumcision, screening blood products and donated organs for 
HIV, and increased alcohol tax were all effective in reducing HIV infection among target populations in a cost-effective 
manner.
Conclusion: We found very limited local evidence regarding the effectiveness of HIV interventions amongst specific 
high risk populations. This underlines the urgent need to prioritise health research resources to assess the effectiveness 
and cost-effectiveness of HIV interventions aimed at reducing HIV infection among high risk groups in Thailand.
Background
Since the introduction of the universal health insurance
coverage policy in 2001, Thailand has sought to further
ensure efficient resource allocation in the health sector
[1]. Evidence-based decision making requires that deci-
sions about health and health care are based on best
available information. To use such an approach it is nec-
essary to appraise what constitutes evidence in relation to
health-enhancing interventions. While the use of effec-
tiveness information alone to justify health care resource
allocation is still common practice, decision makers, aca-
demics and health care professionals are increasingly
interested in cost-effectiveness data to guide policy mak-
ing. Such evaluation are designed to guide explicit
resource allocation decisions by comparing the incre-
mental costs and consequences of alternative health care
interventions [2].
T h a i la n d  is  c l as s i fi ed  as  fa ci n g  a  m ix t u r e  o f  c o n c e n -
trated and generalized epidemics of HIV infection[3],
similar to other countries such as South Africa, Egypt,
Russia, and Papua New Guinea [4]. High HIV prevalence
has been observed among some particular populations,
for example, men who have sex with men, injecting drug
users (IDUs), and female sex workers, while HIV preva-
lence among pregnant women was relatively low (0.8%)
[5]. It is noteworthy that the prioritisation of strategies
for dealing with sexually transmitted infections and HIV/
AIDS was a product of their perceived high disease bur-
den, although often without reliable evidence regarding
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the effectiveness and cost-effectiveness of the interven-
tions themselves. Furthermore, many HIV/AIDS pro-
grams have been implemented without close monitoring,
or rarely incorporated well-defined control or compari-
son groups necessary to identify their actual effect size. In
parallel to these prevention strategies, a policy for univer-
sal antiretroviral treatment has been in operation in Thai-
land since 2001, with almost 150,000 individuals living
with HIV/AIDS currently reaching the program. Evi-
dence from the National AIDS Spending Assessment
indicated a decreasing proportion of expenditure on pre-
vention intervention from 18% in 2000 to 13% in 2004 [6].
Although there were some prior attempts to provide
information for guiding policy decisions regarding
resource allocation towards HIV prevention, these all had
limitations in their applicability to the Thai health care
setting. Bollinger [7] provides an extensive review of the
literature assessing impacts of HIV prevention interven-
tions in developing settings and applied a matrix of effec-
tiveness coefficients to prioritize the interventions. His
major finding is that interventions that included interper-
sonal contact offered a greater impact than interventions
targeting a more general audience; however, the impact
was measured only in terms of sexual behaviour change
and did not include program costs as a prioritizated crite-
rion. Meanwhile, Cohen et al [8] and the second edition
of "Disease Control Priorities in Developing Countries"
(hereafter "DCP2") [9] adopted a 'maximization concept'
by using economic evaluation as the primary resource
allocation criterion but neither of them was considered
applicable to the Thai setting; Cohen et al provide an HIV
prevention cost-effectiveness league table tailored to the
US setting while DCP2 provided policy recommenda-
tions on HIV prevention across a broader range of health
care settings.
This paper addresses the need to assess the usefulness
and value for money of HIV/AIDS prevention interven-
tions. It aims to make a comprehensive list of interven-
tions that are likely to be effective and cost-effective in
the Thai setting. This information can be crucial for guid-
ing public investment to lessen both the short and long-
term impacts of HIV/AIDS in Thailand by re-emphasis-
ing the role of prevention as compared with that of treat-
ment in managing the epidemic.
Methods
Scope and type of interventions
Interventions included in this review were those that
showed evidence of reducing HIV incidence or risk
behaviours likely to effect horizontal and vertical HIV
transmission. The set of interventions was not restricted
to those used in practice in Thailand or funded by the
Thai government. It also covered interventions provided
at all levels, i.e. individuals, groups, and communities
which are likely to be beneficial in the reduction of the
HIV/AIDS epidemic worldwide.
Given that a wide range of interventions were included
in this study, it is imperative that they have clear defini-
tions and detailed information to ensure a better under-
standing of, for example, their precise aims, what their
delivery modes are, and at whom the interventions are
targeted. A lack of clarity and descriptive detail of inter-
ventions makes it difficult to assess and compare either
the effectiveness or cost-effectiveness in different set-
tings. It is also impossible to make sensible recommenda-
tions with regards to policy decision making if there are
no concise definitions for commonly implemented inter-
vention approaches.
It was necessary, therefore, for this study to establish or
adopt a standard structure to define and classify interven-
tions for the prevention of HIV/AIDS. Based on the rec-
ommendations made by UNAIDS [10], HIV prevention
interventions are grouped into five broad categories as
follows:
1. Interventions that affect knowledge, attitude and
beliefs and influence psychological and social correlates
of risk;
2. Harm reduction interventions that lower the risk of a
behaviour, but do not eliminate the behaviour;
3. Biological/biomedical interventions that strive to
reduce HIV infection and transmission risk;
4 .  M i t i g a t i o n  o f  b a r r i e r s  t o  p r e v e n t i o n  a n d  n e g a t i v e
social outcomes of HIV infection;
5. Mitigation of biological outcomes of HIV infection.
However, as the fifth category was not related to HIV
prevention, it was not included in this review. From the
above recommendations, we provide a definition and
classification of each HIV prevention intervention in
additional file 1: Table S1.
Sources of information
We obtained literature published in Thai or English from
1997 to 2008. The studies conducted within a Thai setting
were given a higher priority since they better recognise
the resource and infrastructure limitations that are spe-
cific to the health care system in Thailand, as well as the
effectiveness of interventions which are affected by con-
text specific factors. The review of the Thai literature,
therefore, included both published and unpublished
(grey) literature such as research reports, Master's disser-
tations or Ph.D. theses, which are considered highly rele-
v a n t  t o  t h e  T h a i  c o n t e x t .  I f  l o c a l  d a t a  r e g a r d i n g
effectiveness or cost-effectiveness of an intervention were
not available, then a systematic search of Pubmed and
Cochrane databases was carried out. A broad search
strategy with appropriate MeSH terms and keywords was
used in combination with a filter to restrict type of stud-
ies to systematic reviews, meta-analysis, randomizedPattanaphesaj and Teerawattananon BMC Public Health 2010, 10:401
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controlled trial, case control studies or cohort studies.
Search terms used included 'acquired immunodeficiency
syndrome', 'HIV', 'prevention and control', 'primary pre-
vention', 'intervention studies', or 'early intervention'.
Exclusion criteria were: i) publications of the same study,
ii) descriptive studies, iii) assessment of satisfaction,
knowledge and attitude towards HIV/AIDS, risk behav-
iours and program activities (not outcomes), iv) reports
of case studies, and v) cost analyses.
Effectiveness of interventions
The effectiveness of interventions can be measured in a
number of ways. Figure 1 (adapted from [11]) shows the
concept of outcome hierarchies that emphasize the dif-
ference between 'immediate', 'intermediate' and 'final'
outcomes of HIV interventions. Immediate measures of
effectiveness of HIV interventions are characterised by
change in knowledge, attitude, perception and skills of
the individuals. In many HIV programs, the changes were
reported in terms of trust, caution and received assur-
ances. Further along the continuum, these immediate
changes can subsequently affect health behaviours and
health determinants, for example, condom use, absti-
nence, sharing injection equipments, or fewer sexual
partners. Finally, changes in incidence or morbidity or
mortality should be evaluated as the final or ultimate goal
of the program. The primary criterion for selection of
studies was that they report the effectiveness in terms of
the changes in HIV risk behaviour and HIV incidence.
We deliberately excluded descriptive or qualitative
reports from the review as these most often do not pro-
vide comparable measures of outcome. Studies reporting
outcomes in terms of improvement in attitude or knowl-
edge were also excluded because changes in these are not
always directly associated with behavior change [12].
Cost-effectiveness of interventions
The review included economic evaluation studies that
presented their results in terms of cost per HIV infection
averted, or cost per quality-adjusted life year (QALY)
gained, or cost per disability-adjusted life year (DALY)
averted. This review compared the value for money of
different HIV/AIDS preventive interventions using a
societal viewpoint since it is most relevant to priority set-
ting in health care. However, if the evaluation took the
more limited health care provider perspective, this was
used instead.
Differences in monetary currencies and unit costs
between locations and over time are among the most
commonly cited obstacles to applying economic evalua-
tion findings across different settings. This study adjusted
all cost-effectiveness ratios in a common currency, the
international dollar, at their 2008 value, using national
consumer price index (CPI) and purchasing power parity
(PPP) information from the International Monetary Fund
(IMF) [13].
With regard to the thresholds for considering an inter-
vention to be cost-effective, the Subcommittee for devel-
opment of the National List of Essential Medicines in
Thailand developed its own threshold as a criterion to
include or exclude medicines from the reimbursement
list [14]. Interventions with a cost per QALY gained
below 100,000 THB (approximating the Thai GDP per
capita) are considered favourably for inclusion. Given the
fact that 11.23 QALYs could be saved from one HIV
infection avoided [15], the thresholds for one HIV infec-
tion averted was approximately 90,000 PPP$.
Quality assessment
Systematic reviews and meta-analyses of high quality
RCTs were considered the most favourable data sources
Figure 1 Outcome measures for HIV prevention interventions.
Behaviour 
intentions:
attitude, knowledge, 
trust, caution, 
received assurances 
Immediate 
outcomes 
Final 
outcomes 
Intermediate 
outcomes 
TIME 
Behaviour change 
or risk exposure:
condom use, 
fewer partners 
Health
indicators: 
HIV incidence, 
morbidity, 
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[2]. The advantages of using systematic reviews of clinical
effects are twofold. First, a more precise estimate can be
attained from combining the outcome data from a num-
ber of studies. Second, by using the results from studies
carried out in a range of settings, assuming that these
studies are sufficiently homogenous to be comparable,
the estimate can then be applied to a more general patient
population with different baseline risks, rather than spe-
cifically for a population group selected for an individual
trial. In cases where a meta-analysis of RCT(s) was not
available alternative evidence sources were used in accor-
dance with the hierarchy shown in table 1.
Results
Description of studies
Searching the Thai databases initially identified a total of
932 abstracts (see figure 2). Of these, 890 abstracts were
excluded based on our exclusion criteria. From the full
text review of the remaining 42 papers, only fourteen
papers were found to be relevant and included in the
analysis. Of the 28 papers excluded, 25 papers reported
only immediate outcomes of the HIV prevention pro-
grams. For example, two papers that reported the effec-
tiveness of the distribution of condom vending machines
in the communities, used only numbers of condoms sold
per machine and/or customer's satisfaction as their out-
come measures [16,17]. Three other papers that evalu-
ated drug regimens for the prevention of vertical HIV
transmission, were excluded because the regimen under
investigation(AZT regimens), is no longer used in clinical
practice in Thailand [18-20]. The remaining 14 studies
[21-34] were included in the analysis.
We identified 1,394 abstracts from the international lit-
erature (see figure 3). After reading the abstracts, 1,203
studies were eliminated because they were editorials,
descriptive, or qualitative reports. In addition, we also
excluded a number of studies that assessed the effective-
ness and cost-effectiveness of programs for the preven-
tion of mother-to-child HIV transmission because
relevant Thai studies had already been identified. The full
text of the remaining 191 studies was reviewed and 66
studies [35-100] were considered relevant and included in
the analysis in the final stage.
Additional file 2: Table S2 summarizes the effectiveness
and cost-effectiveness of each HIV prevention interven-
tion based on the reviews of domestic and international
studies. It was not surprising that a much larger propor-
tion of effectiveness and cost-effectiveness studies were
conducted in international settings, mainly the US and
Sub-Saharan Africa. In both the Thai and the interna-
tional settings there were more effectiveness studies than
cost-effectiveness ones (11 and 48 effectiveness studies in
the Thai and international settings, respectively, versus 3
and 18 cost-effectiveness studies in each of the respective
settings).
Most of the assessments focused on interventions
affecting knowledge, attitudes and beliefs (36/63 or 57%),
followed by biological/biomedical interventions (16/63 or
25%), harm reduction interventions (9/63 or 15%) and,
lastly, mitigation of barriers to prevention and negative
social outcomes of HIV infection (2/63 or 3%).
Effectiveness and cost-effectiveness of HIV prevention 
intervention
The findings demonstrated that male condoms use, street
outreach programs, programs for the prevention of
mother-to-child HIV transmission, circumcision, and
needle and syringe programs were the only interventions
to show strong evidence of reducing HIV infection
among target populations.
Figure 4 compares the cost per HIV infection averted of
each HIV prevention intervention. It can be seen that the
cost-effectiveness ratios vary largely, ranging from 70
PPP$ per HIV infection averted for screening blood
product to 2,000,000 PPP$ per HIV infection averted for
Table 1: Levels of clinical evidence
A+ Systematic reviews & meta-analyses of RCTs or RCT(s) 
conducted in Thailand with a very low risk of bias*.
A Systematic reviews & meta-analyses of RCTs or RCT(s) 
conducted internationally with a very low risk of bias.
B+ Systematic reviews & meta-analyses of RCTs or RCT(s) 
conducted in Thailand with a high risk of bias.
B Systematic reviews & meta-analyses of RCTs or RCT(s) 
conducted internationally with a high risk of bias.
C+ Systematic reviews of case control or cohort studies 
conducted in Thailand with a very low risk of 
confounding, bias, or chance and a high probability 
that the relationship is causal.
C Systematic reviews of case control or cohort studies 
conducted internationally with a very low risk of 
confounding, bias, or chance and a high probability 
that the relationship is causal.
D+ Case control or cohort studies conducted in Thailand 
with a high risk of confounding, bias, or chance and a 
significant risk that the relationship is not causal.
D Case control or cohort studies conducted 
internationally with a high risk of confounding, bias, or 
chance and a significant risk that the relationship is not 
causal.
* A bias is a systematic error, or deviation from the truth, in results 
or inferences.Pattanaphesaj and Teerawattananon BMC Public Health 2010, 10:401
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community-based education for low income women. It is
likely that biological/biomedical interventions (high-
lighted in blue) are more cost-effective than those inter-
ventions affecting knowledge, attitudes and beliefs
(highlighted in pink).
Figure 5 presents the modification of the figure 4
according to levels of HIV prevalence in settings where
economic evaluations were conducted. It indicates that
interventions performing in high HIV prevalence settings
(e.g. screening blood products and donated organ for
HIV or school-based sex education program in settings
with high HIV epidemic) are likely to be cost-effective
whereas interventions performing in low HIV prevalence
settings (e.g. school-based sex education program in set-
tings with low HIV prevalence or community-based edu-
cation for low income women) are less likely to be cost-
effective.
Figure 6 summarises the findings from the review and
prioritises HIV prevention interventions based on effec-
tiveness and cost-effectiveness evidence. The table pres-
ents results by targeted population including female sex
workers, IDUs, men who have sex with men and serodis-
cordant couples, who are currently the major sources of
HIV infection in Thailand.
Figure 2 Literature review profile of the Thai literature.
932 abstracts identified through the search
890 abstracts were excluded
14 papers included in the analysis 
  - 3 experimental studies on HIV vaccine, workplace-based education for 
male conscripts, and provider-initiated voluntary HIV screening; 
  - 6 quasi-experimental studies on workplace-based education for female sex 
workers, school-based education for young people, and community-based 
education for injecting drug users; 
  - 3 economic evaluation studies on the prevention of vertical HIV 
transmission, HIV vaccine, and screening blood products; 
- 2 observational studies of a ‘100% condom’ program and prevention of 
vertical HIV transmission 
28 papers excluded after 
reviewing their full texts 
42 full papers were reviewed
Figure 3 Literature review profile of the international literature.
1,203 abstracts were excluded 
66 papers included in the analysis 
- 14 systematic reviews/meta-analyses; 
- 18 economic evaluation studies; 
- 15 randomised controlled trials; 
- 15 quasi-experimental studies; 
-  4 observational studies 
1,394 abstracts identified through the search 
191  full papers were reviewed 
125 papers excluded after 
reviewing their full texts Pattanaphesaj and Teerawattananon BMC Public Health 2010, 10:401
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Those interventions proven to be both effective and
cost-effective for female sex workers were: voluntary HIV
counselling and testing, peer education, and male and
female condom use. Community-based education and
workplace-based education proved to be effective, but no
evidence regarding the value for money among female
sex workers was found. Although the use of microbicides
is still in the trial phase, the evidence so far suggests that
microbicides and sexually transmitted infections (STI)
control were not effective in preventing HIV transmis-
sion amongst female sex workers.
Condom use was proven to be the only effective and
cost-effective intervention for men who have sex with
men while voluntary HIV counselling and testing demon-
strated effectiveness but lacked cost-effectiveness infor-
mation. Community-based education was clinically
effective but cost-ineffective. Peer education and STI
control were shown to be ineffective amongst this popu-
lation.
For injecting drug users, voluntary HIV counselling and
testing, condom use, needle and syringe programs, and
street outreach were amongst the programs shown to be
both effective and cost-effective. Needle social market-
ing, peer education, and substitution treatment demon-
strated clinical effectiveness but were unsupported by
economic evidence. Community-based education, HIV
vaccines, STI control and post-exposure prophylaxis were
shown to be ineffective in the prevention of HIV trans-
mission amongst IDUs.
Figure 4 Summary of cost-effectiveness data for HIV prevention intervention by type of interventions (PPP$ 2008 per HIV infection avert-
ed).Pattanaphesaj and Teerawattananon BMC Public Health 2010, 10:401
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Condom use was the only interventions proven to be
both effective and cost-effective for serodiscordant cou-
ples. Voluntary HIV counselling and testing was proven
to be clinically effective but no cost-effectiveness infor-
mation was available. STI control was not effective in pre-
venting HIV transmission amongst this population.
With respect to information availability, voluntary HIV
counselling and testing and condom use were the only
interventions with extensive evaluations concerning
effectiveness and cost-effectiveness across the different
population groups. The main identified information gaps
were for the following interventions: routine (provider-
initiated) voluntary HIV screening at healthcare settings,
introduction of female condoms, HIV vaccine, male cir-
cumcision, microbicides, and post-exposure prophylaxis.
The evidence was particularly scarce for some of the tar-
geted populations, namely serodiscordant couples, prison
inmates and health care workers.
Discussion
This review demonstrated several barriers to the use of
effectiveness and cost-effectiveness evidence for policy
decision making or program reorientation regarding
HIV/AIDS. First, a lack of proper assessment about the
effectiveness and/or cost-effectiveness outcomes of many
interventions poses a significant challenge in making evi-
dence-based health policy decisions. We found that most
domestic studies evaluated the effectiveness or cost-
effectiveness of interventions using only immediate mea-
sures such as knowledge, attitudes, perception, and skills.
Figure 5 Summary of cost-effectiveness data for HIV prevention intervention by type of interventions and HIV prevalence (PPP$ 2008 per 
HIV infection averted).Pattanaphesaj and Teerawattananon BMC Public Health 2010, 10:401
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Figure 6 Summary of findings by intervention and targeted population. Abbreviations FSW - female sex worker; MSM - men who have sex with 
men; IDU - injecting drug user; SDC - serodiscordant couples; Preg - pregnant women; PI - prison inmate; HCW - healthcare worker; Young - people 
aged 10-24 years old; G pop - general people.
Interventions FSW MSM IDU  SDC  Preg  PI  HCW  Young  G  pop
I. Interventions that affect knowledge, attitude and beliefs and influence psychological and social 
correlates of risk 
Abstinence-only programs                            
Abstinence-plus programs                            
Community-based education                             
Mass media campaigns                             
Peer education    
 
  
       
  
Routine (provider-initiated) voluntary HIV 
screening at healthcare settings 
                          
School-based sex education programs 
(+ life skills) 
                          
Voluntary HIV counselling and testing  (VCT) 
(+ STI clinic and condom distribution) 
                          
Workplace-based education 
(+condom distribution / free STI clinic) 
                          
II. Harm reduction interventions that lower the risk of a behaviour, but do not eliminate the behaviour 
Condom use 
(availability and accessibility) 
                          
Introduction of  female condoms                            
Needle and syringe program                             
Needle social marketing                            
Street outreach                            
III. Biological/biomedical interventions that strive to reduce HIV infection and transmission risk 
HIV vaccine                            
STI control                            
Mass or community treatment of sexually 
transmitted  infections 
                          
Male circumcision                            
Microbicides                            
Post-exposure prophylaxis                             
Prevention of mother-to-child 
transmission of HIV 
                          
Screening blood products and donated 
organs for HIV 
                          
Substitution treatment                            
Using nucleic acid test screening (NAT) of 
volunteer blood donations 
                          
IV. Mitigation of barriers to prevention and negative social outcomes of HIV infection 
Increased alcohol tax
 
                          
Microfinance                            
Microfinance 
(combined with education) 
             
 
￿
The colour of effectiveness and cost-effectiveness 
Colours Effectiveness  Cost-
effectiveness  Description 
 dark green  Yes  Yes  The intervention proven to be effective and cost-effective 
 light green  Yes  Data not 
available 
The intervention proven to be effective but no evidence regarding cost-
effectiveness 
 orange  Yes  No  The intervention proven to be effective but not cost-effective 
 red  No  No, data not 
available  The intervention proven to be neither effective nor cost-effective 
white  Data not 
available 
Data not 
available 
No evidence concerning effectiveness or cost-effectiveness of the 
intervention 
 grey    The intervention is not relevant or used for particular target population Pattanaphesaj and Teerawattananon BMC Public Health 2010, 10:401
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The use of such immediate measures severely limits the
usefulness of the evaluations because they do not allow
for the comparison of value for money across different
types of interventions, due to variation in outcome mea-
surement. In addition, these immediate outcomes may
not be of primary interest to decision makers or health
care planners when they consider health resource alloca-
tion.
Second, although high quality evidence was available
for assessing many of the interventions' effectiveness, a
major concern is the strength of evidence used to gener-
ate cost-effectiveness information. For example, many
cost-effectiveness studies obtained the their effectiveness
data from more bias-prone sources, such as expert opin-
ion; in the case of the economic evaluation of HIV vac-
cine particularly unconvincing assumptions were applied
[99]. This problem is also found in the economic apprais-
als of STI control and mass media campaigns which
showed inconclusive clinical effects but good value for
money [98,100]. Economic evaluation can be useful for
guiding policy decisions only when it is performed cor-
rectly and reported accurately; these findings clearly
depict barriers that would diminish the use of cost-effec-
tiveness evidence to inform policy decisions.
Third, despite the emphasis we placed on finding local
information on HIV prevention, the majority of studies
identified in our reviews originate in other settings.
Although their transferability/generalizability to the Thai
settings might be questionable, it remains necessary to
rely on these to inform policy making. In addition, most
studies reporting the effectiveness and cost-effectiveness
of HIV interventions were identified from international
publications rather than domestic journals or grey litera-
ture (see table 2). This reflects the fact that good quality
studies conducted both in Thailand or elsewhere are
likely to be published in international journals. Thus, it is
sensible to recommend that the international databases
are still major sources of information, and can be used to
inform decision making about the effectiveness and cost-
effectiveness of HIV prevention interventions.
The findings in this study are mostly consistent with
the international literature, and notably the DCP2 find-
ings [9]; male condoms, street outreach programs, pro-
grams for the prevention of mother-to-child HIV
transmission, and circumcision were the only interven-
tions to show strong evidence of reducing HIV infection
among target populations. The DCP2 also identified
these interventions, with the exception of circumcision,
in its recommendations for concentrated epidemic areas
including East Asia and the Pacific region. The differ-
ences between the recommendations from DCP2 and our
findings are as follows:
• Although it was recommended in DCP2, there was a
lack of strong evidence to indicate that community-based
education offers good value for money in the prevention
of HIV infection in either low or high HIV prevalence set-
tings.
• In our review there were very consistent results show-
ing that screening blood products and donated organs for
HIV is very cost-effective while there was little reference
to this intervention in the DCP2.
• This study found that interventions that aim to miti-
gate barriers to prevention and negative social outcomes
of HIV infection such as increased alcohol tax and micro-
financing also held promise of being effective. These
interventions should be assessed in the future.
The differences between the DCP2 report and this
study may be explained by the fact that DCP2 did not
employ a comprehensive and systematic search for evi-
dence, resulting in a number of published and unpub-
lished studies being excluded. Furthermore, this study
gave a higher priority for evidence from Thai context at
which the recommendations are primarily aimed, while
the DCP2 report aims to provide policy recommenda-
tions across a broader range of health care settings.
It is interesting to note that we found very limited local
information about HIV interventions amongst specific
high risk populations (i.e. IDUs, men who have sex with
men, female sex workers, and young people). Of the nine
interventions conducted in Thailand identified in our
Table 2: Review profile of domestic literature
Type of literature Initial search Review of full text Final inclusion
Articles published in domestic journals 528 16 1
Articles published in international journals 111 11 5
Theses/dissertations 99 11 5
Research reports 24 3 2
Conference proceedings 170 1 1
Total 932 42 14Pattanaphesaj and Teerawattananon BMC Public Health 2010, 10:401
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review, only one study focused on a high risk group,
assessing an HIV vaccine for injecting drug users. These
findings underline the urgent need to prioritize health
research resources to assess the effectiveness and cost-
effectiveness of HIV interventions aimed at the reduction
of HIV infection among high risk groups.
Caution should be exercised when comparing the effec-
tiveness and cost-effectiveness data in this study to
inform policy decision making. Firstly, because many
studies were conducted in various settings with different
sized target populations, different HIV prevalence, differ-
ent attitudes towards HIV/AIDS, and varying socio-eco-
nomic and cultural determinants of behavioral responses
to interventions; these factors would greatly affect not
only the effectiveness of the intervention but also its
value for money.
Se c o n d l y ,  a l t h o u g h  w e  h a v e  m a d e  e x p l i c i t  c r i t e r i a  t o
judge whether the effectiveness studies/data are good
enough to be used in decision making, there was no such
standard to measure the quality of cost-effectiveness
studies. We found that most of the effectiveness studies
are of good quality (mainly in the 1st or 2nd hierarchy)
but we are in doubt of the quality of data used in many of
the cost-effectiveness studies.
Lastly, it is important to recognize that effectiveness
and cost-effectiveness are not the only criteria in guiding
health care rationing and that political and ethical dimen-
sions and other societal values such as equity can also
play significant roles in decision making processes. How-
ever, these issues were not under consideration in this
study.
Conclusion
This study found that school based-sex education plus
life-skill programs, voluntary and routine HIV counsel-
ling and testing, male condoms, street outreach pro-
grams, needle and syringe programs, programs for the
prevention of mother-to-child HIV transmission, male
circumcision, screening blood products and donated
organs for HIV, and increased alcohol tax showed strong
evidence and value for money in reducing HIV infection
among target populations.
We found very limited local evidence regarding the
effectiveness of HIV interventions among high risk popu-
lations in Thailand. This underlines the urgent need to
prioritise health research resources to assess the effec-
tiveness and cost-effectiveness of HIV interventions
aimed at reducing HIV infection among high risk groups.
This review also demonstrated several limitations in
using effectiveness and cost-effectiveness evidence for
policy decision making concerning HIV/AIDS. First, a
lack of proper assessment about the effectiveness and/or
cost-effectiveness outcomes of many interventions poses
a significant challenge in making evidence-based health
policy decisions and program reorientation. Second,
although good quality evidence was available for assess-
ing intervention effectiveness, a major concern is the
strength of evidence used to generate the cost-effective-
ness information. Third, although we put more effort into
identifying local information on HIV prevention, a
majority of the studies included in the final analysis were
identified from international databases rather than local
sources, and may not be entirely applicable in the Thai
context.
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